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Abstract
Background: Sonic hedgehog (Shh) signaling regulates cell growth during embryonic development, tissue homeostasis and
tumorigenesis. Concentration-dependent cellular responses to secreted Shh protein are essential for tissue patterning. Shh
ligand is covalently modified by two lipid moieties, cholesterol and palmitate, and their hydrophobic properties are known
to govern the cellular release and formation of soluble multimeric Shh complexes. However, the influences of the lipid
moieties on cellular reception and signal response are not well understood.
Methodology/Principal Findings: We analyzed fully lipidated Shh and mutant forms to eliminate one or both adducts in
NIH3T3 mouse embryonic fibroblasts. Quantitative measurements of recombinant Shh protein concentration, cellular
localization, and signaling potency were integrated to determine the contributions of each lipid adduct on ligand cellular
localization and signaling potency. We demonstrate that lipid modification is required for cell reception, that either adduct
is sufficient to confer cellular association, that the cholesterol adduct anchors ligand to the plasma membrane and that the
palmitate adduct augments ligand internalization. We further show that signaling potency correlates directly with cellular
concentration of Shh ligand.
Conclusions/Significance: The findings of this study demonstrate that lipid modification of Shh determines cell
concentration and potency, revealing complementary functions of hydrophobic modification in morphogen signaling by
attenuating cellular release and augmenting reception of Shh protein in target tissues.
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Introduction
The Hedgehog (Hh) family of signaling proteins are secreted
from localized sources and elicit concentration-dependent cellular
responses to specify tissue pattern during development and
homeostasis [1,2]. Proper Hh ligand distribution and reception
are essential for the full repertoire of graded cellular responses and
human birth defects and malignancies are attributed to the
misregulation of Hh signaling [3,4,5,6]. A unique biochemical
property of the secreted Hh signaling domain is covalent
modification by cholesterol and palmitate. Following signal
sequence cleavage, cholesterol serves as a cofactor in an
autocatalytic intramolecular cleavage reaction and remains
covalently bound to the carboxy-terminal Gly residue of the
newly formed signaling domain [7,8,9,10,11]. The second
hydrophobic modification is catalyzed by the acyl-transferase
Skinny hedgehog, which results in the amide linkage of palmitate
to the amino-terminal Cys residue of the signaling domain
[12,13,14].
Hydrophobic modification confers membrane affinity such that
the secreted signaling domain is tightly associated with Hh-
generating cells [8,9,15]. The cellular release of cholesterol
modified Hh ligand is regulated by the transmembrane protein
Dispatched [16,17,18]. Thus, one biological function of the lipid
moieties is to restrict the spatial deployment of Hh morphogens.
Hh is secreted as multivalent particles [19,20] whose formation
requires the presence of both lipid additions to the signaling
domain [19,21,22]. Thus, it has been proposed that both lipid
moieties are required for long range signaling [19,21,22,23].
Conspicuously, however, lipid modification is not a requisite for
high-affinity binding of Hh ligand to Patched1 (Ptc1) and other
receptor complex proteins [24,25,26,27,28].
A clear understanding of how lipid modification influences
signal reception has been hampered by conflicting results.
Notably, the earliest in vitro signaling assays utilized purified
Sonic hedgehog (Shh) lacking both cholesterol and palmitate
adducts [29] to elicit the full repertoire of graded signaling
responses in explanted chick neural plate ectoderm [30,31].
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adducts abolished [21] or greatly diminished signaling [26,27].
In Drosophila and mouse embryos, localized expression of Hh
lacking only the palmitoyl moiety decreased long range signaling
[14,21], whereas the localized expression of Hh lacking only
cholesterol broadened tissue distribution and range of signaling
[9,16,32,33].
A major constraint of in vivo model systems to elucidate the
influences of the lipid adducts on Hh signaling is the inability to
distinguish an effect on tissue distribution, and thus local
concentration, from an effect on signal potency. Another
limitation centers on tissue-specific differences in sensitivity to
Hh signaling [32]. With regard to cell-based assays, we report a
profound loss of signal reception sensitivity in cloned and high-
passage cell lines used in prior studies [22,34,35]. To circumvent
some of these limitations, early-passage NIH3T3 fibroblasts and
assays with enhanced sensitivity were used to integrate quantitative
measurements of Shh concentration, cellular localization, and
potency to evaluate the influences of lipid modification on Shh
signaling. We demonstrate that the lipid adducts serve critical
functions in cellular reception, governance of cell concentration,
and signal potency of Shh ligand.
Materials and Methods
Preparation of Complementary DNA (cDNA) Constructs
The pRK5-Shh construct was used to express full length mouse
Shh. The pRK5-ShhN construct carries an open reading frame
truncated after Gly-198 and was used to express Shh lacking
cholesterol [31]. To eliminate palmitoylation, PCR site-specific
mutagenesis by overlap extension [36] was performed with pRK5-
Shh as cDNA template (PlatinumH Blue PCR SuperMix,
Invitrogen) with the following primers: 1) 59 -CCC GGG CTG
GCC GCT GGG CCC GGC AG- 39 (mutates Cys-25 to Ala-25;
ShhC25A) and 2) 59-CCC GGG CTG GCC AGT GGG CCC
GGC AG- 39 (mutates Cys-25 to Ser-25; ShhC25S). To eliminate
both cholesterol and palmitate modification, the primers listed
above were used in conjunction with 59-GCG GCC AAA TCC
GGC GGC TAG GTC GAC TGC-39 to create a stop codon
after Gly-198. All constructs were sequenced for verification
(Genepass Inc.).
Cell Culture and Transfection
NIH3T3 mouse embryonic fibroblasts cultured in 6-well plates
were co-transfected (FuGeneH 6, Roche) with Shh constructs (Shh,
ShhC25A, ShhC25S, ShhN, or ShhNC25A) over a range of 0.06
ng to 1000 ng in two fold increments, pEGFP-C1, a Gli-reporter
(pGL3–8xGli-luciferase) [35,37], pCMV-LacZ, (a transfection
control with a 9:1 ratio of Gli-reporter:LacZ), and variable
amounts of empty vector (pcDNA) to normalize the total DNA
quantity in each well. Shh constructs were eliminated from the co-
transfection mix for controls. Twelve hours later, cells were
changed to low-serum medium (0.5% calf serum) and cultured for
an additional forty hours [38,39] (Figure S1). Cells were then
processed by flow cytometry, ELISA, or used chemiluminescent
signaling assays. Cells from each well (9.6 cm
2) were harvested and
allocated for flow cytometry, Guava EasyCyte and ELISA. All
experiments were conducted in parallel with identical culture
conditions. The conditioned medium from each well was also
collected for ELISA.
Figure 1. Schematics of experimentation. (A) Shh ligand lipidated with palmitate and cholesterol was generated from a full-length Shh open
reading frame. Point mutation of the amino-terminal C25 to either an A or S was introduced to eliminate palmitoylation (ShhC25A, ShhC25S,
ShhNC25A and ShhNC25S). Introduction of a stop codon after G198 eliminates cholesterol modification (ShhN, ShhNC25A, and ShhNC25S). (B) Assays
of recombinant Shh protein concentration, cellular localization, and signaling were performed on transfected NIH3T3 fibroblasts harvested from the
same or parallel wells. ELISA measurements of Shh protein concentration, flow cytometric analysis of cell expression, and chemiluminescence
signaling assays in NIH3T3 fibroblasts co-transfected with recombinant Shh, EGFP, Gli-reporter, and LacZ were integrated to determine the
contributions of each lipid adduct on Shh secretion, cellular localization, and signaling potency.
doi:10.1371/journal.pone.0021353.g001
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(pGL3–8xGli-luciferase) and pCMV-LacZ (in a 9:1 ratio) changed
to low-serum medium with exogenous recombinant Shh protein,
incubated at 37uC for 42 hours, and then analyzed by ELISA or
chemiluminescent signaling assays. For recombinant Shh protein,
HEK293T cells were transfected with a Shh expression construct
(Shh, ShhC25A, ShhC25S, ShhN, ShhNC25A, or ShhNC25S),
and changed to low serum medium. Thirty-six hours later,
conditioned medium was filtered and concentrated (AmiconH
Ultra-15 centrifugation filter units; Millipore). For control assays,
NIH3T3cells were transfected asabove and exposed to conditioned
medium from untransfected HEK293T cells.
Flow Cytometry
NIH3T3 cells were dissociated with trypsin (Invitrogen) and then
washed at 4uC with FACS buffer (phosphate-buffered saline, 2%
fetal bovine serum, and 0.05% sodium azide). Anti-Shh antibody
(5E1, Developmental Studies Hybridoma Bank) was fluorescently
conjugated as directed by the manufacturer (ZenonH Alexa Fluor-
647; Invitrogen) and cells were then stained with 5E1-Alexa Fluor-
647 anti-Shh antibody (8 mg/mL diluted at 1:10,000), washed with
FACS buffer and fixed in 2% paraformaldehyde. To measure total
cellular expression levels, cells were permeabilized and fixed (BD
Cytofix/Cytoperm) prior to staining. To measure internal expres-
sion, cells were first incubated with a saturating level of unlabeled
5E1 antibody (1:50; Figure S2) for 1 hour, washed with FACS
buffer, and then fixed, permeabilized and stained with fluorescent
conjugated 5E1 antibody. Samples were run on a 5-laser BD LSRII
system (BD Biosciences) and at least 50,000 viable cells were
analyzed per sample. Non-viable cells were excluded from analysis
based on forward and side scatter profiles as well as 7-
aminoactinomycin D (Invitrogen) staining. Data were acquired
using FACSDiva (BD Biosciences) and analyzed using FloJo
(Treestar, Inc). Both EGFP (excited at 488 nm Argon Laser, and
detected with a 505LP mirror and a 530/30 bandpass filter) and
Alexa 647 (excited at 633 nm He-Ne Laser, detected with no LP
mirror and a 670/14 bandpass filter) signals were analyzed
simultaneously in all cells. Mean fluorescence index (MFI) was
calculated by multiplying the percentage of positively stained cells
by the mean fluorescence intensity (cells with fluorescence intensity
greater than 99% of control transfected cells (Figure S3)). For cell
counts, NIH3T3 cells were suspended in phosphate-buffered saline
(PBS) and analyzed with the Guava EasyCyte as directed by the
manufacturer (GuavaH ViaCountH Reagent; Guava Technologies).
Enzyme-linked immunosorbent assay (ELISA)
Culture medium was collected and then NIH3T3 cells were
washed three times with PBS and lysed in RIPA Buffer (50 mM
Tris-HCl at pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.1% SDS,
1% NP-40) with protease inhibitors (Complete Mini, Roche
Applied Science) on a rotator for 4 hours at 4uC. Recombinant
Shh protein concentration was measured in the cell lysate and
culture medium as instructed by the manufacturer (DuoSetH
ELISA Development System, R&D Systems). ELISA was
performed on a series of eight, two-fold dilutions with a starting
concentration of 1:1 (reagent diluent:sample). The colorimetric
optical density was measured at 450 nm (FLUOstar Omega,
BMG Labtech). An internal positive control (purified Shh protein,
0.063 nM) was included in each assay for normalization. Culture
medium and cell lysate from untransfected NIH3T3 cells were
used as negative controls.
Shh Signaling Assays
Chemiluminescence (Dual-LightH Luciferase and ß-Galactosi-
dase Reporter Gene Assay System) was measured in lysed (Passive
Lysis Buffer; Promega) NIH3T3 cells as directed by the
manufacturer (FLUOstar Omega, BMG Labtech) .
Figure 2. Shh lipid modifications enhance cellular association.
(A) Each of the constructs conferred dose dependent and similar
expression levels of recombinant Shh protein. Shown are the sums of
protein measurements in cell lysate and culture medium from NIH3T3
cells transfected with a range of cDNA for Shh, ShhC25S, ShhN, and
ShhNC25S. (B) Precise quantification of recombinant Shh protein
concentrations in either the cell lysate or culture medium revealed
both cholesterol and palmitate modifications confer cellular association.
Shown are the averages of Shh protein measurements from cells
transfected with cDNA (62.5 ng to 500 ng in two fold increments). With
both lipid adducts, 89.7% of Shh was recovered in the lysate and 10.3%
was secreted in the culture medium. Less protein was measured in
lysates from cells expressing Shh without a palmitate adduct, (76% for
ShhC25A and 56.3% for ShhC25S). Examination of the culture medium
from cells transfected with ShhN by HPLC (Figure S1) revealed the
presence of two species of protein, one that was palmitoylated
(ShhN+pal) and one that was not (ShhN2pal). Approximately 13% of
secreted ShhN was palmitoylated (ShhN+pal). The portion of cell-
associated ShhN (36.5%) represents the ShhN+pal species because in the
absence of either lipid moiety, less than 0.5% of ShhNC25A and
ShhNC25S protein was recovered from cell lysate. Protein measure-
ments were performed in replicates of four (6 s.e.m.) *** p,0.001
compared to Shh-transfected cells.
doi:10.1371/journal.pone.0021353.g002
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21353Figure 3. Cholesterol is required for expression of Shh on the cell surface. Shown are flow cytometric data from NIH3T3 fibroblasts co-
transfected with recombinant Shh variants (0.125 ng) and EGFP (1000 ng), and stained with 5E1-Alexa 647 conjugated antibody. Total cell staining
was measured in permeabilized cells and surface staining was measured in non-permeabilized cells. Internal staining was measured in cells that were
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The half-maximal excitatory concentrations (EC50) were
determined by obtaining the non-linear regression (plotted with
a 95% confidence interval) of transformed (X=Log(X)) and
normalized (highest value set at 100) data. Significance was
determined using one-way analysis of variance and a Bonferroni
post-test with 99% confidence intervals. All statistical analyses
were performed using GraphPad Prism. To determine the cell-
pretreated with a saturating level of unlabeled 5E1 antibody prior to permeabilization and staining with 5E1-Alexa 647. Scatter plots (A–R) and
histograms (S–X) of 5E1-Alexa 647 staining in transfected (GFP-positive) and untransfected (GFP-negative) cells revealed that cholesteryl modification
is required for surface expression (compare E, H & K to N & Q and T to W). In Shh transfected cells (GFP
+/5E1-Alexa 647
+) and untransfected cells
(GFP
2/5E1-Alexa 647
+), the highest ligand staining levels are measured with fully lipidated Shh (D). Removal of either lipid moiety results in decreased
cellular retention (G, J, M, P). Shh surface expression (E) is reduced in the absence of palmitate (H, K) and eradicated by the removal of cholesterol (N,
Q). Internal expression is also diminished in the absence of either lipid moiety (F, I, L, O, R). Histograms of the number of 5E1-Alexa 647-positive cells
within GFP-positive or GFP-negative cells reiterate the above findings (S–X). Experiments were done in replicates of two or more and representative
images are shown.
doi:10.1371/journal.pone.0021353.g003
Figure 4. Distinct properties of cholesterol and palmitate modification on cellular localization of Shh ligand. (A–E) Distinct influences
of the cholesterol and palmitate modifications on Shh cellular localization were revealed by quantification of mean fluorescence indices (MFI) for 5E1-
Alexa 647staining ofNIH3T3 fibroblasts co-transfectedwith recombinant Shh (0.06 ng to1000 ng)andEGFP (1050 ng). (A–C) Intransfectedcells (GFP
+),
removal of both lipid adducts greatly diminished total cell MFI (compare ShhNC25A to Shh in A), and abolished surface expression (compare ShhNC25A
in B and C). In ShhN transfected cells, where the vast majority of cell associated recombinant ligand appears to represent a palmitoylated species
(ShhN+pal), surface expression was greatly diminished and concomitantly internal expression was enriched (compare ShhN in A, B & C). Conversely,
following removal of the palmitate alone (ShhC25A & ShhC25S) surface expression was maintained (B) while internal expression levels were reduced to
that of recombinant ligand lacking any lipid-modification (compare ShhC25A and ShhC25S to ShhNC25A in C). (D) To quantify the amount of cell-
associated Shh ligand that was expressed on the surface, the MFI for internal staining was subtracted from that for total cell staining. Removal of both
lipid adducts eliminates surface expression, and only 2.9% of cell-associated ShhN (ShhN+pal) was localized to the cell surface. (E) Correspondingly,
surface staining with 5E1-Alexa 647 in untransfected cells (GFP
2) was only measureable for recombinant Shh with cholesterol modification (Shh,
ShhC25A,& ShhC25S). Controlcellswere mock transfected,andMFI isshownrelative tocontrol.Experiments weredoneinreplicates oftwoormore and
representative images are shown. NS, not significant (p.0.05); ***, p,0.001 (6 s.e.m.) compared to Shh transfected cells.
doi:10.1371/journal.pone.0021353.g004
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fected cells, the total amount of protein measured in the lysate by




Either lipid adduct is sufficient for cellular association of
Shh ligand
The lipid adducts, cholesterol and palmitate, tightly associate
Shh ligand with Hh-generating cells [8,10,12,15]. To quantify the
contribution of each lipid modification to cellular association,
NIH3T3 fibroblasts were co-transfected with expression vectors
for recombinant Shh (ranging from 0.06 ng to 1000 ng in two-fold
increments) and EGFP, and the concentrations of recombinant
Shh protein in culture media and cell lysates were measured by
ELISA (Figure 1). All the constructs conferred similar dose-
dependent total expression levels of recombinant forms of Shh
protein (Figure 2A). The proportions of cell-associated and
secreted Shh, however, were significantly altered by lipid
modification. Whereas only 89.7% of lipid-modified Shh was cell
associated, virtually all ($99.5%) was released into the culture
medium when both lipid modifications were removed (ShhNC25A
and ShhNC25S), indicating a strict requirement of lipid
modification for cellular association (Figure 2B). Removal of the
palmitoyl adduct alone decreased the cellular association of
recombinant Shh (76.7% of ShhC25A and 56.3% of ShhC25S;
Figure 2B), and the enhanced association of ShhC25A compared
to ShhC25S is consistent with the greater hydrophobicity of
alanine compared to serine [26]. Removal of the cholesteryl
adduct resulted in the retention of 36.5% ShhN (Figure 2B),
suggesting a greater contribution of cholesterol to cellular
association. The efficiency of ShhN palmitoylation, however, can
be reduced in in vitro expression systems [12]. Consistent with this
observation, we determined that in our transfection system
approximately 13% of secreted recombinant ShhN was palmitoy-
lated (ShhN+pal), while the remaining secreted protein lacked both
cholesteryl and palmitoyl adducts (ShhN2pal; Figure S4 and
Methods S1). Thirty-six percent of recombinant ShhN protein was
measured in cell lysates, and appears to represent palmitoylated
protein (ShhN+pal) as less than 0.5% of recombinant Shh protein
lacking both lipid modifications (ShhNC25A and ShhNC25S) was
cell associated (Figure 2B). Therefore, in transfected NIH3T3
fibroblasts, approximately 81% of ShhN+pal, was cell associated
and 19% was secreted. These data demonstrate that either lipid
modification is sufficient to confer cell association, however, ligand
quantification by ELISA demonstrates that the palmitoyl adduct
provides a greater contribution than previously recognized by
Western blotting [15].
Cholesterol modification is required for cell surface
retention and palmitate augments ligand internalization
The contribution of each lipid adduct to cellular association was
corroborated by flow cytometric analyses with the anti-ShhN
monoclonal antibody 5E1 [40]. The 5E1 antibody blocks Hh
signaling, and although 5E1 does not recognize Shh well by
Western blotting [24,41], excellent reactivity (low nanomolar) to
the native conformation of Shh has been measured by FACS,
ELISA and signaling competition assays [26,40,42,43,44]. Nota-
bly, 5E1 binds a surface domain of Shh formed by non-continuous
residues in the Shh linear sequence that is maintained in the
Figure 5. Quantification of the contributions of the lipid
moieties to cellular distribution of Shh. Shown are integrated
data from ELISA and flow cytometric measurements of recombinant
forms of Shh expressed inside cells, on the cell surface, or secreted in
the culture medium. The proportion of cell associated and secreted Shh
protein for each recombinant expression construct was determined by
ELISA measurements of cell lysate and conditioned medium in cells
transfected with two fold increments of 62.5–500 ng cDNA (Figure 2B).
From the same culture wells, the percentage of Shh protein expressed
on the surface and within cells was determined by flow cytometric
measurements (Figure 4). To determine the proportion of surface
protein expression, the quantity of cell associated Shh was multiplied
by the percentage expressed on the cell surface as calculated in
Figure 4D. The remaining cell associated Shh protein represents the
internal proportion for each recombinant construct. ***, p,0.001;
*, p,0.05 (6 s.e.m.)
doi:10.1371/journal.pone.0021353.g005
Figure 6. Lipid modification enhances Shh association with
receiving cells. NIH3T3 cells were incubated at 37uC for 42 hours with
medium containing various concentrations of recombinant Shh protein.
After extensive washes, the cells were lysed and analyzed by ELISA. The
highest levels of protein were recovered from cell lysates following
incubation with Shh-conditioned medium. Recovery of ligand was
greatly diminished when both lipid adducts were removed (ShhNC25A),
and restored with either cholesteryl (ShhC25S) or palmitoyl (ShhN+pal)
modification alone. Experiments were performed in replicates of four,
and representative data are shown.
doi:10.1371/journal.pone.0021353.g006
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Staining with Alexa 647-labeled 5E1 antibody was performed to
detect recombinant Shh protein expression in transfected cells
(GFP-positive) and neighboring cells (GFP-negative). Total cellular
expression was measured in permeabilized cells and surface
expression was measured in non-permeabilized cells. To detect
internal expression levels of recombinant Shh protein, non-
permeabilized cells were first incubated with saturating levels of
Figure 7. Shh signaling potency is directly related to cellular concentration of ligand. NIH3T3 fibroblasts were co-transfected with
expression plasmids for recombinant Shh (Shh, ShhC25S, ShhN, or ShhNC25S), EGFP, Gli-reporter (8xGli-luciferase) and LacZ, changed to low-serum
medium for 40 hours, and then analyzed for chemiluminescence. (A–D) Shown are relative luciferase values as a function of transfected recombinant
Shh cDNA. ShhNC25A signaling was significantly reduced in comparison to Shh, ShhC25S, and ShhN. (E–H) Analysis of relative luciferase activity as a
function of recombinant ligand expressed per transfected cell (pg/cell) revealed that all of recombinant forms of Shh signaled with equal potency.
Solid line denotes non-linear regression and the dotted lines denote confidence intervals of 95%. Experiments were performed in replicates of three
(6 s.e.m.).
doi:10.1371/journal.pone.0021353.g007
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647-labeled 5E1 antibody (Figure S2).
Quantitative flow cytometric analysis of Shh staining within
permeabilized GFP-positive cells revealed that both lipid adducts
are required to confer the highest degree of cell association
(compare Figure 3D to 3P). Correspondingly, we observed a
decrement in the percentage of GFP-positive cells that expressed
ShhC25A (Figure 3G), ShhC25S (Figure 3J), and ShhN
(Figure 3M). These findings were reiterated by examining total
cell expression levels over a range of recombinant Shh expression
in GFP-positive cells (Figure 4A), and are consistent with an
interpretation of the ELISA studies that either lipid moiety can
confer cell association. Yet, distinct contributions of the palmitoyl
and cholesteryl adducts to steady state cell distribution were
revealed. Surface expression was retained in the absence of the
palmitoyl adduct (ShhC25A and ShhC25S; Figures 3H, 3K, 3T
and 4B). Without the cholesteryl adduct, only 2.9% of total Shh
was available on the cell surface while the removal of both lipid
adducts entirely eliminated surface expression (Figure 4D).
Further, the percentage of cell-associated ligand localized to the
surface was not significantly altered by removal of the palmitate
(Figure 4D), indicating that the cholesteryl adduct alone is
sufficient for cell surface expression (Figure 5). Supporting a
requirement of cholesterol for localization to the plasma
membrane, its removal (ShhN and ShhNC25A) virtually abolished
surface staining (Figures 3N, 3Q, 3T, 4B and 4D). Additionally,
the highest internal levels of recombinant Shh were measured
within ShhN-transfected cells (Figure 4C). In conjunction with the
ELISA data revealing that the ShhN+pal species is cell associated,
these data indicate that in the absence of a cholesterol tether to the
cell surface the palmitoyl adduct strongly enhances ligand
internalization (Figure 5, note that 78.6% of ShhN+pal is expressed
inside cells).
Analysis of 5E1 staining in GFP-negative fibroblasts suggests
that lipid modification serves analogous functions in receiving
cells. In Shh-transfected fibroblasts, 5E1 staining was mea-
sured in a significant population of GFP-negative cells
(Figure 3D and 3V-3X) and was largely confined to the cell
surface (compare 3E to 3F). Conversely, staining in GFP-
negative cells was markedly reduced in the absence of both
lipid adducts (ShhNC25A; Figure 3P-3R and 3V-3X). Thus,
lipid modification strongly enhances ligand association with
receiving cells. When solely modified by cholesterol (ShhC25A
and ShhC25S), a similar population of GFP-negative cells
stained with 5E1 antibody (Figure 3V-3X) and surface
localization of ligand predominated (Figure 3G-3L). These
results support mathematical modeling studies postulating that
cholesterol is the predominant lipid determinant for cell
surface association [18]. Notably, surface staining in
GFP-negative cells was measurable only for cholesterol
modified Shh ligands (Figure 4E). The mean fluorescence
indices (MFI) for ShhC25A and ShhC25S surface staining
were higher than for Shh in GFP-negative cells as a
consequence of the higher levels of cholesterol modified ligand
in the culture media under these conditions (Figure 2B).
Furthermore, the enhanced surface MFI of ShhC25A with
respect to ShhC25S is consistent with the greater hydropho-
bicity of alanine compared to serine [26].
Lipid modifications dictate cell concentration and
signaling potency of Shh ligand
The evaluation of 5E1 staining in GFP-negative cells supports a
predominant role for cholesterol modification in the association of
recombinant Shh ligand with target cells. To directly test the
influence of the lipid modifications on ligand association with
receiving cells, NIH3T3 fibroblasts were exposed to varying
quantities of recombinant Shh protein, and the corresponding
amounts of cell-associated ligand was measured by ELISA
(Figure 6). By this assay, the highest degrees of cellular association
were observed following incubation with fully lipid-modified Shh.
Removal of both lipid adducts (ShhNC25S) greatly diminished
recovery of ligand in the cell lysate and ShhN+pal and ShhC25S
demonstrated equivalent dose-dependent cellular association.
Collectively, these data provide direct evidence that the lipid
modifications are essential for association with target cells.
There are conflicting reports regarding the roles of lipid
modification and ligand signaling. The signaling potency of
Shh ligand devoid of cholesteryl and palmitoyl adducts in
C3H10T1/2 cells can be enhanced by the introduction of a
wide variety of hydrophobic modifications [26]. Conversely,
several studies have reported that removal of either the
cholesteryl or palmitoyl adduct abolishes ligand multimeriza-
tion and signal response in NIH3T3 fibroblasts [19,21,22]. We
analyzed NIH3T3 cells, which have been used most commonly
for Hh signaling assays [19,21,22,35,39], and found that signal
response was greatly reduced in cloned and high-passage lines
(Figure S5). In order to determine whether levels of cell-
associated ligand correlate with signal response, parallel wells
of low-passage and highly responsive NIH3T3 fibroblasts co-
transfected with expression vectors for recombinant Shh, GLI-
reporter, and EGFP were assayed. In one set of wells, relative
GLI-reporter activity was measured and in the other set the
Table 1. Relative signaling potencies of recombinant forms of Shh ligand.
Recombinant Shh Cell transfection Conditioned Media
EC50 (pg/cell) Relative to Shh EC50 (nM) Relative to Shh
Shh 0.0017 1 0.81 1
ShhC25A 0.0077 4.5 5.04 6.2
ShhC25S 0.0026 1.6 7.71 9.5
ShhN 0.00093 0.6 ND ND
ShhNC25A ND ND 311 384
ShhNC25S 0.0031 1.8 104.1 128.5
The half maximal effective concentration (EC50) of Shh and recombinant variants lacking one or both lipid modifications was determined in signaling assays with NIH3T3
fibroblasts that were either transfected with recombinant Shh, or to which Shh conditioned medium was added exogenously. ND, not determined.
doi:10.1371/journal.pone.0021353.t001
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GFP-positive cells. When signaling activity was expressed
relative to transfected DNA for recombinant Shh, signaling
levels were comparable for Shh, ShhC25S, and ShhN and
markedly reduced for ShhNC25S (Figure 7A–7D). Yet, when
expressed relative to the cellular quantity of ligand, the half-
maximal effective concentrations (EC50) for each of the
recombinant ligands, including ShhNC25S, were nearly
identical (Figure 7E–7H and Table 1). The concentrations of
recombinant variants of Shh protein recovered from the
culture medium was well below the respective EC50 calculated
in conditioned medium signaling assays, indicating that
signaling was mediated by cell-associated ligand in the
transfection assays (see Figure 8 and compare Table 1 and
Table 2). These data strongly support a direct relationship
between signaling potency and cellular concentration of
ligand.
When signaling was measured for ligand delivered exogenously
to NIH3T3 fibroblasts, the maximal signaling level was highest
with Shh and diminished by removal of one or both of the lipid
adducts (ShhC25A.ShhN.ShhNC25A; Figure 8A–8E). The
complex signaling curve measured for ShhN negated the ability
to calculate an EC50 in this instance, possibly because of the
presence of two species of ligand (ShhN+pal and ShhN2pal).
However, separation of ShhN+pal from ShhN2pal in ShhN
conditioned medium by hydrophobic interaction chromatography
revealed that ShhN+pal elution fraction contained the highest
signaling potency (Figure S4 and Methods S1). Furthermore, the
EC50 calculated for Shh, ShhC25A and ShhNC25A correlate
directly with measurements of their cell-association properties
(Figure 6), supporting the conclusion that the lipid modifications
regulate Shh ligand association with receiving cells and dictate
signaling potency.
Discussion
Hedgehog proteins are among several secreted signaling
proteins that are covalently modified by lipid moieties
(Reviewed in [45]). Hedgehog family members are the only
proteins that are known to be modified by cholesterol [11], and
this discovery cultivated attention on the influences of lipids on
morphogen signaling (Reviewed in [46]). The influences of the
lipid modification on ligand release and association with
multivalent particles have been well characterized
[8,10,15,19,20]. The roles of the lipid adducts in signal response
have been less well defined, however, in part due to constraints
of in vivo model systems to distinguish effects on tissue
distribution from signal potency [21,23,32,33] and of in vitro
systems with poorly responsive cell lines and qualitative assays of
ligand concentration [19,21,22]. Utilizing highly responsive
NIH3T3 fibroblasts and quantitative assays to integrate
measurements of recombinant Shh concentration, cellular
localization, and signaling, we demonstrate that the mem-
brane-anchoring properties of cholesterol and palmitate govern
the cellular reception of Shh and that signaling potency
correlates directly with cellular concentration of Shh ligand.
In conjunction with prior studies, these findings illustrate
complementary functions of the lipid modifications to attenuate
release and enhance reception of Shh signal.
Our studies indicate that either lipid moiety is sufficient to
enhance cellular association and increase signaling potency.
Cholesterol modification, however, tethers ligand to the plasma
membrane while palmitoylation alone is not sufficient for retention
on the cell surface. These distinct properties identified in our in
vitro assays may explain opposing and seemingly puzzling effects on
limb patterning observed in prior in vivo studies following
expression of Shh lacking either the palmitoyl or cholesteryl
adduct in the zone of polarizing activity (ZPA). In the mouse limb
bud, digit number is reduced by targeted deletion of Skinny
Hedgehog (Skn) to abrogate Shh palmitoylation and interpreted to
indicate a requirement for a multimeric Shh protein complex in
long range signaling [21]. Long range signaling, however, is
enhanced by removal of the Shh processing domain to eliminate
cholesterol modification, indicating that cholesterol restricts the
long-range movement of Shh protein across the limb bud [33]. In
both instances, removal of either cholesterol or palmitate disrupts
Shh multimerization [19,21]. Therefore, our data suggest that the
defects in digit specification in Skn
-/- limb buds [21] are consistent
with Shh protein secreted from the ZPA with reduced potency,
resulting from absence of palmitoylation, and restricted long-range
movement, due to cholesterylation. Conversely, in limb buds
engineered to express ShhN in the ZPA [33], ligand with reduced
potency is distributed more broadly due to the absence of
cholesterol anchorage to implement low-threshold signaling in the
anterior limb bud. Collectively, these observations support a
model whereby multimeric or multivalent Shh complexes are not
strictly required for Shh signaling, but rather represent a
mechanism for delivering soluble and potent lipidated ligand over
a range of cells during tissue patterning.
In the absence of Shh ligand, Ptc1 functions to inhibit the
pathway by suppressing the activity of the transmembrane
protein Smoothened (Smo) [38]. Upon binding with Shh, Ptc1
inactivation allows Smo to initiate signaling [24,47,48] through
the Gli family of transcription factors (Reviewed in [49]). In
vertebrates, primary cilia appear to be the principal site where
Shh signaling is regulated by reciprocal subcellular localizations
of Ptc1 and Smo [50,51]. According to this model, Ptc1 localized
to the base of primary cilia inhibits the lateral transport of Smo,
and binding of Shh to Ptc1 activates signaling by reciprocal
movement of Ptc1 out of the cilium and Smo into the cilium
[52,53]. Ptc1 function and the dynamics of its subcellular
localization are not fully understood. Sub-stoichiometric levels
of Ptc1 suffice to regulate Smo, and the levels of free Ptc1 protein
determine the degree of pathway activity as well as the amount of
Shh ligand required for pathway stimulation [38]. Ptc1
expression is increased by pathway activation [54]. In NIH3T3
fibroblasts, endogenous Ptc1 is barely detectable by immunoflu-
orescence, and upon pathway activation becomes highly enriched
in primary cilia [53]. Against this background, our data may
clarify the observation in cell-based assays that lipophilic
modification of Shh enhances signaling potency without affecting
binding affinity for Ptc1 [12,26,27]. Notably, binding assays were
performed with cells transfected with a Ptc1 construct truncated
Figure 8. Lipid modification enhances signaling potency of Shh. NIH3T3 fibroblasts were co-transfected with Gli-reporter and LacZ, and
changed to low-serum medium containing Shh, ShhC25A, ShhC25S, ShhN, ShhNC25A, or ShhNC25S protein. (A–F) Shown are relative luciferase
values as a function of Shh protein (nM) added. (G–K) Normalized relative luciferase measurement of the Log EC50 for each variant of recombinant
Shh revealed decreased signaling potency following removal of one or both lipid adducts. An EC50 could not be calculated for ShhN-conditioned
medium because of the complex signaling curve (D). Solid lines denote non-linear regression, and the dotted lines denote confidence intervals of
95%. Experiments were performed in replicates of three (6 s.e.m.)
doi:10.1371/journal.pone.0021353.g008
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[12,26,27,48]. We measured a profound reduction in signaling
potency and corresponding curtailment in cellular association of
unmodified Shh (ShhNC25S and ShhNC25A), suggesting that
anchorage of Shh ligand to target cells by lipid modification is
critical for access to Ptc1 and other receptor complex proteins.
This concept raises the intriguing notion that the lipid
modification may also serve to create a reservoir of membrane-
associated ligand to maintain durable signaling as cellular levels
of Ptc1 are increased. As such, the tethering of Shh ligand to
receiving cells could directly influence the temporal and spatial
gradients of Shh signaling [55,56,57].
Supporting Information
Figure S1 Time course of reporter activity in Shh signaling
assays. (A) To determine the linear phase of reporter activity,
NIH3T3 fibroblasts were co-transfected with expression plasmids
for recombinant Shh (125 ng, 15.63 ng, 1.95 ng, and 0 ng),
EGFP, Gli-reporter and LacZ, changed to low serum medium and
assayed at varying time points. (B) For signaling assays with
conditioned medium, NIH3T3 cells were co-transfected with Gli-
reporter and LacZ, changed to low serum medium containing
ShhN protein, and then assayed at the indicated time points.
Experiments were performed in replicates of three (6 s.e.m.).
(EPS)
Figure S2 Determination of concentration of unlabeled
5E1 antibody required to saturate cell surface staining
with labeled 5E1 antibody. NIH3T3 cells were transfected
with Shh cDNA (500 ng) and EGFP (1100 ng), while control cells
were transfected with EGFP (1100 ng) alone. The cells were then
incubated with varying concentrations of unlabeled 5E1 antibody,
fixed, permeabilized, and stained with 5E1 antibody conjugated to
Alexa 647 (1:10000). Saturation, or capping, of surface staining
was observed with unlabeled 5E1 antibody over a range of
dilutions from 1:50 to 1:2000.
(EPS)
Figure S3 Representative histograms of total, surface,
and internal cell staining for Shh. Shown are histograms for
the fluorescent intensity of total (A), surface (B), and internal (C)
cell staining for Shh within viable EGFP-positive cells (filled
histogram) relative to control cells (unfilled histogram).
(EPS)
Figure S4 Two distinct species of recombinant protein
in ShhN conditioned medium. (A–B) ShhNC25S and ShhN
conditioned media were subjected to hydrophobic interaction
chromatography and collected fractions were examined by
ELISA. A single peak of ShhNC25S protein was measured in
early elution fractions (A). Two peaks of protein were measured for
ShhN conditioned medium, one that corresponded to Shh protein
devoid of lipid modifications (ShhNC25S), and a second in later
elution fractions indicative of greater hydrophobicity. (C–D) ShhN
protein in fractions 13 and 22 was quantified by ELISA and
assayed for signaling in NIH3T3 fibroblasts transfected with Gli-
reporter and LacZ (6 s.e.m.).
(EPS)
Figure S5 Variable signaling responses among lines of
NIH3T3 fibroblasts. (A) NIH3T3 cellsstablytransfected with Gli-
reporter and LacZ (Shh LIGHT Z3 cells) (35) exhibited a dose
dependent, but low response to Smoothened Agonist (SAG). (B–C)
Three different NIH3T3 cell lines transiently transfected with Gli-
reporter and LacZ demonstrated marked differences in signaling
competency with pathway activation by co-transfection with Shh (B),
the addition of ShhN conditioned medium,or SAG (C). Shh LIGHT
Z32 cells and lines 1 and 2 were maintained and passaged over long
periods of time. Line 3 was newly purchased from ATCC and
expandedin culture over one passage. Fresh aliquots of cryopreserved
cells from line 3 were used in all of the experiments in this study.
Experiments were performed in replicates of three (6 s.d.).
(EPS)
Methods S1 Column fractionation and analysis. Condi-
tioned media (DMEM with N2 supplement; Invitrogen) from
recombinant ShhN and ShhNC25S transfected and control
(untransfected) HEK293T cells were collected, filtered, and then
loaded (1 mL loop) on a 15PHE Tricorn 5/100 column (GE
Healthcare Life Sciences) equilibrated in buffer (3.9 M ammoni-
um sulfate, 50 mM Tris pH 8). Prior to loading, samples were
brought up to a final concentration of 1.5 M ammonium sulfate
using a 3.9 M saturated ammonium sulfate in ddH2O stock.
Bound proteins were eluted after 12 mL wash in equilibration
buffer by a 70 mL linear salt gradient beginning with 100%
equilibration buffer at fraction 7 to 100% elution buffer (50 mM
Tris pH 8) ending at fraction 42. HPLC was performed at 4uC
using the Amersham Biosciences A ¨KTA Purifier P-900 (GE
Healthcare Life Sciences). Fractions were collected in 2 mL
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